AAAAAA

   
Results: 1-25 | 26-34
Results: 1-25/34
SHOULD ALPHA-INTERFERON BE INCLUDED AS STANDARD TREATMENT IN MULTIPLE-MYELOMA
Authors: LUDWIG H FRITZ E ZULIAN GB BROWMAN GP
Citation: H. Ludwig et al., SHOULD ALPHA-INTERFERON BE INCLUDED AS STANDARD TREATMENT IN MULTIPLE-MYELOMA, European journal of cancer, 34(1), 1998, pp. 12-17
LEAD UPTAKE BY PICEA-ABIES SEEDLINGS - EFFECTS OF NITROGEN-SOURCE ANDMYCORRHIZAS
Authors: JENTSCHKE G MARSCHNER P VODNIK D MARTH C BREDEMEIER M RAPP C FRITZ E GOGALA N GODBOLD DL
Citation: G. Jentschke et al., LEAD UPTAKE BY PICEA-ABIES SEEDLINGS - EFFECTS OF NITROGEN-SOURCE ANDMYCORRHIZAS, Journal of plant physiology, 153(1-2), 1998, pp. 97-104
GENE FOR TOPOISOMERASE-III MAPS WITHIN THE SMITH-MAGENIS-SYNDROME CRITICAL REGION - ANALYSIS OF CELL-CYCLE DISTRIBUTION AND RADIATION SENSITIVITY
Authors: ELSEA SH FRITZ E SCHOENERSCOTT R MEYN MS PATEL PI
Citation: Sh. Elsea et al., GENE FOR TOPOISOMERASE-III MAPS WITHIN THE SMITH-MAGENIS-SYNDROME CRITICAL REGION - ANALYSIS OF CELL-CYCLE DISTRIBUTION AND RADIATION SENSITIVITY, American journal of medical genetics, 75(1), 1998, pp. 104-108
ANEMIA IN CANCER-PATIENTS
Authors: LUDWIG H FRITZ E
Citation: H. Ludwig et E. Fritz, ANEMIA IN CANCER-PATIENTS, Seminars in oncology, 25(3), 1998, pp. 2-6
ANEMIA OF CANCER-PATIENTS - PATIENT SELECTION AND PATIENT STRATIFICATION FOR EPOETIN TREATMENT
Authors: LUDWIG H FRITZ E
Citation: H. Ludwig et E. Fritz, ANEMIA OF CANCER-PATIENTS - PATIENT SELECTION AND PATIENT STRATIFICATION FOR EPOETIN TREATMENT, Seminars in oncology, 25(3), 1998, pp. 35-38
THE VAI VAINOX(R) TECHNOLOGY FOR STAINLESS STEELMAKING, REFERENCE APPLICATIONS AND FUTURE-DEVELOPMENTS
Authors: DAUM T STEINS J FRITZ E PIRKER H RAMASEDER N
Citation: T. Daum et al., THE VAI VAINOX(R) TECHNOLOGY FOR STAINLESS STEELMAKING, REFERENCE APPLICATIONS AND FUTURE-DEVELOPMENTS, Revue de métallurgie, 95(10), 1998, pp. 1247-1266
PRESENCE OF A P53 GENE DELETION IN PATIENTS WITH MULTIPLE-MYELOMA PREDICTS FOR SHORT SURVIVAL AFTER CONVENTIONAL-DOSE CHEMOTHERAPY
Authors: DRACH J ACKERMANN J FRITZ E KROMER E SCHUSTER R GISSLINGER H DESANTIS M ZOJER N FIEGL M ROKA S SCHUSTER J HEINZ R LUDWIG H HUBER H
Citation: J. Drach et al., PRESENCE OF A P53 GENE DELETION IN PATIENTS WITH MULTIPLE-MYELOMA PREDICTS FOR SHORT SURVIVAL AFTER CONVENTIONAL-DOSE CHEMOTHERAPY, Blood, 92(3), 1998, pp. 802-809
IMMUNOHISTOCHEMICAL EVALUATION OF CATHEPSIN-D EXPRESSION IN COLORECTAL-CANCER
Authors: MAYER A FRITZ E FORTELNY R KOFLER K LUDWIG H
Citation: A. Mayer et al., IMMUNOHISTOCHEMICAL EVALUATION OF CATHEPSIN-D EXPRESSION IN COLORECTAL-CANCER, Cancer investigation, 15(2), 1997, pp. 106-110
PATIENT PREFERENCES FOR INTERFERON-ALFA IN MULTIPLE-MYELOMA
Authors: LUDWIG H FRITZ E NEUDA J DURIE BGM
Citation: H. Ludwig et al., PATIENT PREFERENCES FOR INTERFERON-ALFA IN MULTIPLE-MYELOMA, Journal of clinical oncology, 15(4), 1997, pp. 1672-1679
MYCORRHIZAL COLONIZATION AND LEAD DISTRIBUTION IN ROOT TISSUES OF NORWAY SPRUCE SEEDLINGS
Authors: JENTSCHKE G FRITZ E MARSCHNER P RAPP C WOLTERS V GODBOLD DL
Citation: G. Jentschke et al., MYCORRHIZAL COLONIZATION AND LEAD DISTRIBUTION IN ROOT TISSUES OF NORWAY SPRUCE SEEDLINGS, Zeitschrift fur Pflanzenernahrung und Bodenkunde, 160(3), 1997, pp. 317-321
OVEREXPRESSION OF A TRUNCATED HUMAN TOPOISOMERASE-III PARTIALLY CORRECTS MULTIPLE ASPECTS OF THE ATAXIA-TELANGIECTASIA PHENOTYPE
Authors: FRITZ E ELSEA SH PATEL PI MEYN MS
Citation: E. Fritz et al., OVEREXPRESSION OF A TRUNCATED HUMAN TOPOISOMERASE-III PARTIALLY CORRECTS MULTIPLE ASPECTS OF THE ATAXIA-TELANGIECTASIA PHENOTYPE, Proceedings of the National Academy of Sciences of the United Statesof America, 94(9), 1997, pp. 4538-4542
UNTITLED
Authors: FRITZ E
Citation: E. Fritz, UNTITLED, Forbes, 1997, pp. 20-20
SHORT SURVIVAL OF PATIENTS WITH MULTIPLE-MYELOMA AND A P53 GENE DELETION - A STUDY BY INTERPHASE FISH
Authors: DRACH J ACKERMANN J KROMER E FRITZ E SCHUSTER R GISSLINGER H ZOJER N FIEGL N HEINZ R LUDWIG H HUBER H
Citation: J. Drach et al., SHORT SURVIVAL OF PATIENTS WITH MULTIPLE-MYELOMA AND A P53 GENE DELETION - A STUDY BY INTERPHASE FISH, Blood, 90(10), 1997, pp. 1072-1072
THE YEAST TEL1 GENE CAN PARTIALLY SUBSTITUTE FOR ATM IN SUPPRESSING HYPERRECOMBINATION AND RADIOSENSITIVITY
Authors: FRITZ E PETES T MEYN MS
Citation: E. Fritz et al., THE YEAST TEL1 GENE CAN PARTIALLY SUBSTITUTE FOR ATM IN SUPPRESSING HYPERRECOMBINATION AND RADIOSENSITIVITY, American journal of human genetics, 61(4), 1997, pp. 245-245
GENETIC DISSECTION OF SMITH-MAGENIS-SYNDROME - HAPLOINSUFFICIENCY OF TOPOISOMERASE-III AND 19 NEW MARKERS AND ESTS WITHIN 17P11.2
Authors: ELSEA SH FRITZ E SCHOENERSCOTT R ADELL RA MEYN MS PATEL PI
Citation: Sh. Elsea et al., GENETIC DISSECTION OF SMITH-MAGENIS-SYNDROME - HAPLOINSUFFICIENCY OF TOPOISOMERASE-III AND 19 NEW MARKERS AND ESTS WITHIN 17P11.2, American journal of human genetics, 61(4), 1997, pp. 702-702
MAXIMAL ANDROGEN BLOCKADE IN COMBINATION WITH METHOTREXATE FOR TREATMENT OF METASTATIC PROSTATE-CANCER
Authors: SAGASTER P FLAMM J MICKSCHE I FRITZ E DONNER G LUDWIG H
Citation: P. Sagaster et al., MAXIMAL ANDROGEN BLOCKADE IN COMBINATION WITH METHOTREXATE FOR TREATMENT OF METASTATIC PROSTATE-CANCER, Journal of cancer research and clinical oncology, 122(3), 1996, pp. 171-176
HIV DIFFUSION PATTERNS AND MOBILITY - GENDER DIFFERENCES AMONG DRUG-USERS
Authors: MCCOY HV CORREA R FRITZ E
Citation: Hv. Mccoy et al., HIV DIFFUSION PATTERNS AND MOBILITY - GENDER DIFFERENCES AMONG DRUG-USERS, Population research and policy review, 15(3), 1996, pp. 249-264
RECOMBINANT-HUMAN-ERYTHROPOIETIN FOR THE CORRECTION OF CANCER-ASSOCIATED ANEMIA WITH AND WITHOUT CONCOMITANT CYTOTOXIC CHEMOTHERAPY - REPLY
Authors: LUDWIG H FRITZ E
Citation: H. Ludwig et E. Fritz, RECOMBINANT-HUMAN-ERYTHROPOIETIN FOR THE CORRECTION OF CANCER-ASSOCIATED ANEMIA WITH AND WITHOUT CONCOMITANT CYTOTOXIC CHEMOTHERAPY - REPLY, Cancer, 78(5), 1996, pp. 1144-1145
RECOMBINANT-HUMAN-ERYTHROPOIETIN FOR THE CORRECTION OF CANCER-ASSOCIATED ANEMIA WITH AND WITHOUT CONCOMITANT CYTOTOXIC CHEMOTHERAPY - REPLY
Authors: LUDWIG H FRITZ E SUNDAL E
Citation: H. Ludwig et al., RECOMBINANT-HUMAN-ERYTHROPOIETIN FOR THE CORRECTION OF CANCER-ASSOCIATED ANEMIA WITH AND WITHOUT CONCOMITANT CYTOTOXIC CHEMOTHERAPY - REPLY, Cancer, 77(9), 1996, pp. 1961-1961
INCREASE OF BONE-MARROW CELLULARITY DURING ERYTHROPOIETIN TREATMENT IN MYELOMA
Authors: LUDWIG H CHOTT A FRITZ E KRAINER M
Citation: H. Ludwig et al., INCREASE OF BONE-MARROW CELLULARITY DURING ERYTHROPOIETIN TREATMENT IN MYELOMA, Stem cells, 13, 1995, pp. 77-87
ERYTHROPOIETIN FOR CHRONIC ANEMIA OF CANCER - TREATMENT RESULTS AND PREDICTION OF RESPONSIVENESS
Authors: LUDWIG H FRITZ E LEITGEB C PECHERSTORFER M SAMONIGG H SCHUSTER J
Citation: H. Ludwig et al., ERYTHROPOIETIN FOR CHRONIC ANEMIA OF CANCER - TREATMENT RESULTS AND PREDICTION OF RESPONSIVENESS, European journal of cancer, 31A, 1995, pp. 7-7
INTERFERON-ALPHA FOR INDUCTION AND MAINTENANCE IN MULTIPLE-MYELOMA - RESULTS OF 2 MULTICENTER RANDOMIZED TRIALS AND SUMMARY OF OTHER STUDIES
Authors: LUDWIG H COHEN AM POLLIACK A HUBER H NACHBAUR D SENN HJ MORANT R ECKHARDT S GUNCZLER P SEEWANN HL SCHULLER J RHYNER K CAVALLI F FRITZ E
Citation: H. Ludwig et al., INTERFERON-ALPHA FOR INDUCTION AND MAINTENANCE IN MULTIPLE-MYELOMA - RESULTS OF 2 MULTICENTER RANDOMIZED TRIALS AND SUMMARY OF OTHER STUDIES, Annals of oncology, 6(5), 1995, pp. 467-476
QUANTIFICATION OF COXIELLA-BURNETII BY POLYMERASE CHAIN-REACTION (PCR) AND A COLORIMETRIC MICROTITER PLATE HYBRIDIZATION ASSAY (CMHA)
Authors: FRITZ E THIELE D WILLEMS H WITTENBRINK MM
Citation: E. Fritz et al., QUANTIFICATION OF COXIELLA-BURNETII BY POLYMERASE CHAIN-REACTION (PCR) AND A COLORIMETRIC MICROTITER PLATE HYBRIDIZATION ASSAY (CMHA), European journal of epidemiology, 11(5), 1995, pp. 549-557
A RANDOMIZED COMPARISON OF THE EFFECT OF 4 ANTIHYPERTENSIVE MONOTHERAPIES ON THE SUBJECTIVE QUALITY-OF-LIFE IN PREVIOUSLY UNTREATED ASYMPTOMATIC PATIENTS - FIELD TRIAL IN GENERAL-PRACTICE
Authors: BOISSEL JP COLLET JP LION L DUCRUET T MOLEUR P LUCIANI J MILON H MADONNA O GILLET J GERINI P DAZORD A HAUGH MC ADELSBACH JM ALBERT F ALEX C ALLAIN D ALVARO J AMOUDRY M ANOUCHIAN P ARMAND M AUTRAN L AZZOPARDI Y BABY Y BAGUET P BAGUR G BAL JM BARBE P BARNEOUD JC BARNET P BASSET P BASSIN M BATTU JL BAUMONT P BAVEREL G BEAUMONT X BENEVISE B BERTAUD P BES H BEUTTER B BEYLI JP BICHET P BILLA JP BLEIBTREU P BLOSSIER JA BODIN J BONINMACON J BONNIN J BOU C BOULDOUYREMAGNIER AM BOURDON C BOURGEA M BOUTTEN E BOUYAC H BOYER D BRAILLON C BRASS G BRETIN D ERIN M BROSSET E BRULET JF BRUN F BUZY A CABANE P CALLIPEL D CAO HP CARNIAUX F CARRERE P CARRIERE A CARTIER JC CASANOVA JF CASILE J CASSET JC CATEL M CERUETTO J CHAMBARD J CHAMPIER R CHANTALOU ML CHAPIRO O CHAPUIS JY CHARLAIX JC CHARMION J CHAUMIE C CHAZERAND P CHEREAU P CHOBERT M CLAUDET H CLAUX G CLEMENCIN J CLEMENT P CLEMENT D CONCAS P CONSTANTIN R COPERE C CORDEL JC COTINAT JP COUTENS F CRESPO F CUERQ J DASSAUD C DEHAAS P DEJULIIS PA DELAHERONNIERE R DELASELLE P DEVESVROTTE P DEGOUY X DEBITUS D DEMEESTERE P DEROME L DEVEAUX JP DEVILLE B DONSIMONI JF DUBOIS JP DUGUE G DUMOULIN J DUNAND JM DUPELLOUX J DUPIN P DUPONT JL DUPRAZ C DUVAL JJ EICHOLZ J ELSAWY A ELHAIK G EMERY JM ENGERRANDDUBRISAY M ENGUENT V ESTEVE M ESTRAN JP EYRAUD P FABRE JM FAGELSON E FAGOT J FAIVRE S FALCOFF H FALCONNET JM FARGE J FARHAT S FAUCHE R FEVRE J FIERE J FILIPELLI M FIVEL C FLEURY M FRITSCH JM FRITZ E FULLERINGER L GADOT M GAMBY A GARNIER B GAUMER R GENTILE F GILBERT JM GILBERT M GIFFARD P GIRARDIER G GIRY R GONIN D GOYARD JP GREFFE R GREMILLET T GROS P GROSS P GUICHARD D GUICHARD JF GUILLAUMOT H GUILLEUX M GUINCHARD B HEITZMANN F HENRY G HOLIVE P HUBAULT JP HUFSHMITT P HUGUES B JALLAIS A JUDES J KANEKO Y KAPSA M KARSENTI B KESPERN A LACASSAGNE L LACOIN F LACOTE G LE QH LEGOAZIOU MF LEANDRIS E LECOMTE P LEFEVRE MF LEGAIN S LEONARDI G LEORIER C LEVET R LODY JM LUCIANI G MAGNIN C MAIRE JL MALFOY A MANDIER R MANEYROL F MARCHAND B MARINO B MARTEL B MARTIN G MAS JL MATTON JF MAZIDJI G MECHIN H MERLE JF MERTUK D MEYRAND B MICHALLET JP MICHAUD C MICHELLIER P MICOLLE JP MOLLARD JM MOREAU A MORON M MOULIN D MULLER R NACCACHE H NICOLAS C NOIROT J NORIS M NOTELET P NOVA B NOVION J ORDONO B OULLION R PAGUESSORHAYE S PAILLARD L PAQUERIAUD JF PARE E PEPIN A PERRAUD JM PERRIER G PERRIN JL PESLE JL PEYRANNE J PEYRARD JP PEYSSON R POMAREL JP PONS B POZZETTO P PRIGENT A RAGETLY P RAMPONNEAU JP RAVEL C RAVIER F RENDU D REPELLIN M REY G GIRAUD PR REYMOND S RIOUFOL J ROBINSON D ROCCAZ D RONZIERE G ROSSO JC ROUCHOUSE B ROULOT C ROUSSEL E ROUSSELOT H SACHETAT P SAGNARD L SALEMBIER A SARAIDARIAN P SAUVAGE F SCAION A SCHREIBER GH SERAILLE M SESBOUE O SESTIER G SEYNAEVE G SILVESTRE J SINTES J SOCIAS JP SOLDNER H SOULA A SOUHAMI B SPY T STAUFFERT O STINKWICH P SYLVAND V TAIEB B TALLON B TALUY E TARROUX M TEDDE F TERRIEN JP TESTARD P THERON E THIBAULT F TISSOT JF TOSETTI MC TOUATI S TOURON P TRAVERS JC TRUONG TK VALLOIRE M VANHILLE JL VANRANST G VAUDEY R VERDIER R VEROT C VIALY R VIE JC VIEL JP VILLARD B VIOLET P VUILLERMOZ B VUILLET B XAMBEU M YAILIAN B ZAKS P
Citation: Jp. Boissel et al., A RANDOMIZED COMPARISON OF THE EFFECT OF 4 ANTIHYPERTENSIVE MONOTHERAPIES ON THE SUBJECTIVE QUALITY-OF-LIFE IN PREVIOUSLY UNTREATED ASYMPTOMATIC PATIENTS - FIELD TRIAL IN GENERAL-PRACTICE, Journal of hypertension, 13(9), 1995, pp. 1059-1067
SUBCELLULAR-LOCALIZATION AND CHARACTERIZATION OF EXCESSIVE IRON IN THE NICOTIANAMINE-LESS TOMATO MUTANT CHLORONERVA
Authors: BECKER R FRITZ E MANTEUFFEL R
Citation: R. Becker et al., SUBCELLULAR-LOCALIZATION AND CHARACTERIZATION OF EXCESSIVE IRON IN THE NICOTIANAMINE-LESS TOMATO MUTANT CHLORONERVA, Plant physiology, 108(1), 1995, pp. 269-275
Risultati: 1-25 | 26-34